Fig. 4
From: Identification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico
Validation of the differential expression of five hub genes in various clinical stages. (a) The correlation of TPX2 expression with clinical stage. (b) The correlation of KIF2C expression with clinical stage. (c) The correlation of CDCA8 expression with clinical stage. (d) The correlation of BUB1B expression with clinical stage. (e) The correlation of CCNA2 expression with clinical stage. ANOVA was used to assess the statistical significance of the differences